A recent study from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and Charité -- Universitätsmedizin Berlin has shaken up the prevailing views on intermittent fasting. The findings reveal that time-restricted eating (TRE), a popular dietary strategy, does not yield significant improvements in metabolic or cardiovascular health when calorie consumption remains constant. Yet, intriguing shifts in the body's internal biological clocks were noted, underscoring the complex relationship between meal timing and our physiology. This research, known as the ChronoFast study and spearheaded by Professor Olga Ramich, was published in the journal Science Translational Medicine.
Time-restricted eating is a specific form of intermittent fasting that confines one’s daily food intake to a window of just ten hours, followed by a fasting period of at least 14 hours. This approach has gained traction as a straightforward method for managing weight and enhancing metabolic health. Previous animal studies indicated that TRE could safeguard rodents against obesity and related metabolic issues. In human trials, benefits like improved insulin sensitivity, better blood sugar and cholesterol levels, and modest weight loss have been reported. Consequently, many have regarded TRE as a promising strategy to prevent conditions such as insulin resistance and diabetes.
However, earlier studies on TRE have produced conflicting results, raising questions about its effectiveness. Some research has struggled to pinpoint whether the observed health improvements stemmed from simply shortening the eating window, unintentional calorie reduction, or a blend of both factors. Moreover, numerous prior investigations did not meticulously monitor calorie intake or consider other variables that might impact metabolic outcomes.
To address these uncertainties, Professor Olga Ramich, who leads the Department of Molecular Metabolism and Precision Nutrition at DIfE and also teaches at Charité -- Universitätsmedizin Berlin, designed the ChronoFast trial. The aim was clear: to determine whether an eight-hour eating window could enhance insulin sensitivity and other metabolic indicators while keeping calorie intake steady.
The ChronoFast study adopted a randomized crossover design involving 31 women who were either overweight or obese. Each participant adhered to two distinct eating schedules for two weeks. One schedule featured early time-restricted eating from 8 a.m. to 4 p.m. (referred to as eTRE), while the other adhered to a later timeframe from 1 p.m. to 9 p.m. (known as lTRE). Throughout both phases, participants consumed nearly identical meals with consistent calorie and nutrient profiles (isocaloric).
Researchers collected blood samples during four clinical visits and administered oral glucose tolerance tests to evaluate glucose and fat metabolism. Continuous glucose monitoring was utilized to observe blood sugar levels over a full day, and detailed records of food intake were kept. Additionally, participants' physical activity was tracked using motion sensors. Collaborating with Professor Achim Kramer from Charité, the team also investigated changes in the body's internal clock through isolated blood cells.
Human physiology operates on circadian rhythms, which align closely with the 24-hour day cycle. Known as circadian clocks (from Latin, meaning 'around a day'), these internal rhythms play a crucial role in regulating various physiological processes, including sleep patterns and metabolic functions. Almost every cell in the human body contains its own internal clock, which can be influenced by elements such as light exposure, physical activity, and the timing of food consumption.
To assess individual circadian phases, Professor Dr. Achim Kramer developed the BodyTime assay. This innovative test requires only a single blood sample to provide a precise snapshot of an individual’s internal timing. The ChronoFast study utilized this method, revealing that meal timing can indeed shift human biological clocks.
Despite initial expectations from previous research, the ChronoFast study did not find any clinically significant alterations in insulin sensitivity, blood sugar levels, blood fats, or inflammatory markers after the two-week interventions. Professor Ramich noted, "Our results suggest that the health benefits observed in earlier studies were likely due to unintended calorie reduction rather than the duration of the eating window itself."
While metabolic measures showed minimal change, the timing of meals did have a notable impact on circadian rhythms. Blood cell analysis indicated that the internal clock shifted by an average of 40 minutes when participants adhered to the later eating schedule as opposed to the earlier one. Those following the later schedule also adjusted their bedtime and wake-up time accordingly. First author Beeke Peters stated, "The timing of food intake serves as a cue for our biological rhythms, much like exposure to light does."
These findings emphasize the critical role of calorie balance in achieving health benefits from intermittent fasting strategies. Professor Ramich concluded, "Individuals seeking to lose weight or enhance their metabolic health should focus not just on the timing of their meals, but also on maintaining a healthy energy balance."
Future research is essential to explore whether combining time-restricted eating with reduced calorie intake could amplify health benefits. Scientists are also keen to delve deeper into how unique individual factors, such as chronotype (a person’s natural preference for morning or evening activities) and genetic predispositions, may influence responses to different eating schedules.
